We are live on ! Find out more
SUPN icon

Supernus Pharmaceuticals
SUPN

53 hedge funds and large institutions have $170M invested in Supernus Pharmaceuticals in 2013 Q2 according to their latest regulatory filings, with 53 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

572% more call options, than puts

Call options by funds: $5.84M | Put options by funds: $869K

Holders
53
Holders Change
+53
Holders Change %
–
% of All Funds
1.73%
Holding in Top 10
3
Holding in Top 10 Change
+3
Holding in Top 10 Change %
% of All Funds
0.1%
New
53
Increased
–
Reduced
–
Closed
–
Calls
$5.84M
Puts
$869K
Net Calls
+$4.97M
Net Calls Change
+$4.97M

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
NMC
1
NEA Management Company
Maryland
$68.5M +$62.7M +10,650,000 New
T. Rowe Price Associates
2
T. Rowe Price Associates
Maryland
$30.5M +$27.9M +4,739,700 New
A
3
Abingworth
United Kingdom
$23.2M +$21.2M +3,600,000 New
O
4
OrbiMed
New York
$16.1M +$14.7M +2,496,200 New
Ameriprise
5
Ameriprise
Minnesota
$5.74M +$5.25M +892,122 New
HVC
6
Healthcare Value Capital
New Jersey
$4.64M +$4.25M +722,314 New
BFA
7
BlackRock Fund Advisors
California
$4.21M +$3.86M +654,647 New
MOACM
8
Mutual of America Capital Management
New York
$3.25M +$2.97M +504,647 New
Vanguard Group
9
Vanguard Group
Pennsylvania
$2.27M +$2.08M +352,883 New
BIT
10
BlackRock Institutional Trust
California
$956K +$875K +148,625 New
Wellington Management Group
11
Wellington Management Group
Massachusetts
$917K +$840K +142,700 New
TCM
12
Tekla Capital Management
Massachusetts
$905K +$829K +140,800 New
WAM
13
Wolverine Asset Management
Illinois
$854K +$783K +132,900 New
FSA
14
Franklin Street Advisors
North Carolina
$743K +$680K +115,500 New
Northern Trust
15
Northern Trust
Illinois
$683K +$626K +106,238 New
TD Asset Management
16
TD Asset Management
Ontario, Canada
$633K +$580K +98,400 New
Millennium Management
17
Millennium Management
New York
$597K +$547K +92,868 New
Bank of New York Mellon
18
Bank of New York Mellon
New York
$459K +$421K +71,420 New
Morgan Stanley
19
Morgan Stanley
New York
$410K +$375K +63,713 New
TAM
20
Tocqueville Asset Management
New York
$405K +$371K +63,000 New
Geode Capital Management
21
Geode Capital Management
Massachusetts
$376K +$344K +58,477 New
TCIM
22
TIAA CREF Investment Management
New York
$357K +$327K +55,536 New
MCM
23
McGlinn Capital Management
Pennsylvania
$352K +$322K +54,700 New
State Street
24
State Street
Massachusetts
$338K +$310K +52,571 New
BCM
25
Bridgeway Capital Management
Texas
$322K +$294K +50,000 New
1
2 3

SUPN Hedge Fund Activity: Q2 2013 in Review

53 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in Supernus Pharmaceuticals (SUPN) for Q2 2013, worth a combined $170M.

Buyers outnumbered sellers: 53 funds opened new SUPN positions and 0 closed out — a net gain of 53 holders — while 0 added to existing stakes and 0 trimmed.

  • 53 institutional investors held Supernus Pharmaceuticals (SUPN) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $170M of Supernus Pharmaceuticals stock for Q2 2013.
  • 53 funds opened new Supernus Pharmaceuticals positions in Q2 2013 and 0 closed out, a net change of +53 holders.

Based on aggregated 13F filings for Q2 2013.